Aventis Ketek CAP Resistance Claim Needs Larger Trials, Advisory Cmte. Says

Aventis Ketek (telithromycin) needs additional studies in more patients with penicillin- and erythromycin-resistant Streptococcus pneumoniae, FDA's Anti-Infectives Advisory Committee said April 26.

More from Archive

More from Pink Sheet